MONCTON, NEW BRUNSWIKCK--(Marketwired - May 29, 2015) - OrganiGram Holdings Inc. (TSX VENTURE:OGI) (OTCQX:OGRMF) (the "Company") will be presenting at the Canada Cannabis Conference, hosted by Jacob Securities Inc., on June 22, 2015
This is the first investor conference of its kind in Canada, and will feature presentations from leading industry experts and executives, as well as 1-on-1 meetings between company representatives and attendees. Topics will include cross-border investing and trading, developments in the Marihuana for Medical Purposes Regulations ("MMRP") program, industry consolidation, patient intake initiatives, and research & development.
| Event Details: |
| June 22, 2015 |
| 7:30 am - 4:30 pm ET |
| Grand Ballroom, Trump Hotel |
| 325 Bay St, Toronto, ON M5H 4G3 |
| Conference website: www.jacobsecurities.com/conference |
| For more information regarding the Conference or to RSVP: |
| Alyssa Wilkinson |
| 416-866-8304 |
| awilkinson@jacobsecurities.com |
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.
On Behalf of the Board of Directors of Organigram,
Roger Rogers, Director & President
Contact Information:
Director of IR & Business Development
OrganiGram Holdings Inc.
(416) 907-4148
brett@organigram.ca